| Serial Number | 79169641 |
| Word Mark | X CHIOME |
| Filing Date | Tuesday, April 28, 2015 |
| Status | 706 - SECTION 71 ACCEPTED |
| Status Date | Monday, February 6, 2023 |
| Registration Number | 5126156 |
| Registration Date | Tuesday, January 24, 2017 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 8, 2016 |
| Description of Mark | The mark consists of a stylized "X" in white, within a blue square. Centered below the "X" is the term "CHIOME" in blue. |
| Goods and Services | Monoclonal antibodies for medical [ or veterinary ] purposes, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; peptides and proteins for medical [ or veterinary ] purposes, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; [ biological and chemical preparations and reagents for medical or veterinary purposes, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; ] medicines for human purposes, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders [ ; medicines for dental purposes, namely, for infectious diseases, neurological diseases or inflammatory diseases; medicines for veterinary purposes, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; medicinal preparations, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; living cells for manufacturing monoclonal antibodies used for medical purposes; cell lines for manufacturing monoclonal antibodies used for medical purposes; living cells for manufacturing monoclonal antibodies used for veterinary purposes; cell lines for manufacturing monoclonal antibodies used for veterinary purposes; biological tissue cultures for medical purposes, namely, for cultivating living cells or cell lines used for manufacturing monoclonal antibodies; dietary supplements for humans; nutritional supplements; dietary supplements for animals; dietetic foods, namely, protein adapted for medical purposes; dietetic beverages, namely, protein-based ready to drink beverages adapted for medical purposes; food for babies; powdered milk for babies; lacteal flour for babies; surgical implants comprised of living tissues; biological implants, namely, a vital processed human or animal connective tissue; disinfectants for hygiene purposes; sanitary sterilising preparations; biocides; preparations for destroying vermin ] |
| Indication of Colors claimed | The color(s) blue and white is/are claimed as a feature of the mark. |
| Goods and Services | Research, product development and quality control services in the field of proteins, antibodies, microorganisms and cells, and consultancy relating thereto; research and development services in the field of antibody technology; biomedical research services; [ design and development of medical technology; research and development in the field of biotechnology; ] pharmaceutical research and development [ ; conducting clinical trials for others in the field of pharmaceutical products; clinical trials for others; technical project studies in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; technical research in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; technical project planning in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; research and development of new products for others; design and development of computer software for use with medical technology; software design and development; providing temporary use of non-downloadable business software; rental of computer software; cloud computing featuring software used for development of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products ] |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 6, 2015 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 6, 2015 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Chiome Bioscience Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Tokyo 151-0071 JP |
| Party Name | Chiome Bioscience Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Tokyo 151-0071 JP |
| Party Name | Chiome Bioscience Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Tokyo 151-0071 JP |
| Event Date | Event Description |
| Friday, August 14, 2015 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, July 30, 2015 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Thursday, August 6, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, August 8, 2015 | ASSIGNED TO EXAMINER |
| Tuesday, August 11, 2015 | APPLICATION FILING RECEIPT MAILED |
| Thursday, August 13, 2015 | NON-FINAL ACTION WRITTEN |
| Friday, August 14, 2015 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, August 14, 2015 | REFUSAL PROCESSED BY MPU |
| Friday, September 4, 2015 | REFUSAL PROCESSED BY IB |
| Thursday, March 17, 2016 | NON-FINAL ACTION E-MAILED |
| Thursday, March 17, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, September 19, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, February 15, 2016 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, February 15, 2016 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, February 15, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, February 19, 2016 | ASSIGNED TO LIE |
| Thursday, February 25, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 25, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, March 17, 2016 | NON-FINAL ACTION WRITTEN |
| Monday, October 3, 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, November 8, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Monday, September 19, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, September 20, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, September 24, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 19, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, October 19, 2016 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, October 19, 2016 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, November 8, 2016 | PUBLISHED FOR OPPOSITION |
| Friday, January 6, 2017 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Friday, May 12, 2017 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, January 24, 2022 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Wednesday, January 4, 2017 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, January 4, 2017 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, January 24, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Monday, April 24, 2017 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, April 25, 2017 | FINAL DISPOSITION PROCESSED |
| Tuesday, April 25, 2017 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, August 4, 2017 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, October 11, 2023 | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Friday, April 18, 2025 | NEW REPRESENTATIVE AT IB RECEIVED |
| Thursday, January 19, 2023 | TEAS SECTION 71 RECEIVED |
| Sunday, January 29, 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Friday, February 3, 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Monday, February 6, 2023 | REGISTERED-SEC.71 ACCEPTED |
| Monday, February 6, 2023 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |
| Friday, October 6, 2023 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Wednesday, October 11, 2023 | INVALIDATION PROCESSED |
| Sunday, November 12, 2023 | PARTIAL INVALIDATION PROCESSED BY THE IB |
| Thursday, October 9, 2025 | INTERNATIONAL REGISTRATION RENEWED |